Due to this, there remains a reliance on chemotherapy; in contrast, in paradigms like epidermal growth factor receptor (EGFR)-mutant lung cancer and anaplastic lymphoma kinase (ALK)-translocated lung cancer, effective targeted therapy has mitigated the need of chemotherapy3. This evidence concerns the gene ALK and lung cancer.